SA PRO
Free Account
Themes
Moderna, Inc.MRNANASDAQ
Loading
OverviewIntelligenceChartsNews

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
22 analysts·High coverage
27%
Rating Distribution
Strong Buy
00%
Buy
627%
Hold
1255%
Sell
418%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 28% above analyst consensus — significant downside expected.

Bear Case
$17.00
-66%
Consensus
$35.67
-28%
Bull Case
$63.00
+26%
Price Range22 analysts
Low
Consensus
High
$17.00
$63.00
Current Target
Current Price
$49.83
Above Target
$14.16

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Mar 3, 2026Jefferies
Jefferies Reiterates Hold Rating on Moderna (MRNA): "cash breakeven guidance is clearer"
Target:$37.00
-25.7%from $49.83
Feb 17, 2026RBC Capital
Moderna price target raised to $30 from $25 at RBC Capital
Target:$30.00
-29.5%from $42.54
Feb 17, 2026Evercore ISI
Moderna price target raised to $35 from $28 at Evercore ISI
Target:$35.00
-19.0%from $43.19
Feb 17, 2026Bernstein
Moderna price target raised to $45 from $35 at Bernstein
Target:$45.00
+6.6%from $42.23
Feb 16, 2026UBS
Moderna price target raised to $36 from $34 at UBS
Target:$36.00
-14.8%from $42.23
Feb 16, 2026Morgan Stanley
Moderna price target raised to $30 from $28 at Morgan Stanley
Target:$30.00
-29.0%from $42.23
Jan 6, 2026UBS
Moderna assumed at Neutral from Buy at UBS
Target:$34.00
-4.7%from $35.66
Dec 12, 2025Morgan Stanley
Moderna price target lowered to $28 from $30 at Morgan Stanley
Target:$28.00
-6.4%from $29.90
Dec 12, 2025Jefferies
Moderna initiated with a Hold at Jefferies
Target:$30.00
+1.3%from $29.62
Nov 21, 2025RBC Capital
Moderna price target lowered to $25 from $28 at RBC Capital
Target:$25.00
+8.2%from $23.10
Nov 21, 2025UBS
Moderna price target raised to $18 from $15 at Leerink
Target:$18.00
-19.5%from $22.36
Nov 21, 2025Piper Sandler
Moderna price target lowered to $63 from $69 at Piper Sandler
Target:$63.00
+181.8%from $22.36
Nov 20, 2025Wolfe Research
Moderna price target raised to $17 from $16 at Wolfe Research
Target:$17.00
-24.0%from $22.36
Nov 17, 2025Berenberg Bank
Moderna price target lowered to $28 from $30 at Berenberg
Target:$28.00
+13.0%from $24.77
Oct 23, 2025UBS
Moderna price target lowered to $40 from $70 at UBS
Target:$40.00
+49.0%from $26.85
Aug 22, 2025Leerink Partners
Moderna price target lowered to $15 from $18 at Leerink
Target:$15.00
-44.7%from $27.12
Aug 1, 2025Citigroup
Moderna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Target:$40.00
+35.3%from $29.56
Aug 1, 2025J.P. Morgan
Moderna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Target:$26.00
-12.0%from $29.56
Aug 1, 2025Evercore ISI
Moderna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Target:$32.00
+8.3%from $29.56
Aug 1, 2025Morgan Stanley
Moderna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Target:$32.00
+8.3%from $29.56
Feb 14, 2025Evercore ISI
Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Target:$50.00
+56.6%from $31.92
Feb 14, 2025J.P. Morgan
Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Target:$45.00
+41.0%from $31.92
Nov 18, 2024Piper Sandler
Moderna (MRNA) PT Lowered to $69 at Piper Sandler
Target:$69.00
+85.1%from $37.27
Nov 18, 2024HSBC
HSBC Upgrades Moderna (MRNA) to Buy
Target:$58.00
-31.7%from $84.93
Oct 17, 2024Bernstein
Moderna initiated with a Market Perform at Bernstein
Target:$55.00
-4.3%from $57.46

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance